inc headquart danver
lead provid medic devic design use
primarili use either cardiac catheter
lab cath lab intervent cardiologist
heart surgeri suit cardiovascular surgeon
patient receiv devic need
prophylact hemodynam support high-risk
angioplasti procedur experienc pre-shock
shock profound cardiogen shock
reason report
price chang estim chang analysi
former price target per share valuat
potenti on-going expans global
acceler organ growth trend excess
rel in-check street expect furthermor opinion
target assum revenu multipl also
estim reflect above-consensu fiscal result
revis guidanc specif increas former
million revenu estim million non-
earn estim
per share respect addit introduc non-
growth guidanc rang approxim
million million compani revis
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
compani sustain core busi growth also leverag achiev long-term
oper margin target target appear increasingli obtain importantli fiscal
oper period support record number patient unit state germani result
addit fund new product develop realiz oper leverag specif sg expenditur
success penetr approxim estim annual patient opportun result relat
fromexpandedreimbursementingermanyandtheestablishmentofformalreimbursementinjapan accordingli
thousand except per share data
 revenu driven record patient us
product revenu
research develop
sell gener administr
 realiz materi leverag compani
continu invest global sale support
compani document stephen estim
consolid statement incom
dollar thousand except per share data
fiscal period
fiscal period
fiscal period
product revenu
research develop
sell gener administr
total incom expens
incom continu oper tax
tax incom continu oper
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
